Content

Events
About

How Can Polymorph Patents Increase Cost Efficiency?

Pharma IQ | 10/13/2010
Mandar Kodgule, Head of Intellectual Property and Strategic Planning at Wockhardt, answers this question as well as offering the top five strategic considerations to sustain a healthy polymorph patent portfolio and to create polymorphic wealth. In this interview with Helen Winsor from Pharma IQ, he also touches upon how the regulatory landscape is changing and what impact it is having on enforceability of polymorph patents. Kodgule also addresses the issue of excessive innovation... To continue reading this story Click Here

Upcoming Events


Pharma Contract Manufacturing

23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now | View Agenda | Learn More


SmartLab Exchange USA

April 21 - 22, 2026
Philadelphia, USA
Register Now | View Agenda | Learn More

MORE EVENTS